ZA961349B - Amplifying sequences vectors comprising these sequences and their uses in compositions for the expression of nucleotide sequences in transfected cells therapeutic and vaccine applications - Google Patents
Amplifying sequences vectors comprising these sequences and their uses in compositions for the expression of nucleotide sequences in transfected cells therapeutic and vaccine applicationsInfo
- Publication number
- ZA961349B ZA961349B ZA961349A ZA961349A ZA961349B ZA 961349 B ZA961349 B ZA 961349B ZA 961349 A ZA961349 A ZA 961349A ZA 961349 A ZA961349 A ZA 961349A ZA 961349 B ZA961349 B ZA 961349B
- Authority
- ZA
- South Africa
- Prior art keywords
- sequences
- expression
- amplifying
- compositions
- vectors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9501937A FR2730735B1 (fr) | 1995-02-20 | 1995-02-20 | Sequences amplificatrices, vecteurs portant ces sequences et leurs utilisations dans des compositions pour l'expression de sequences nucleotidiques dans des cellules transfectees, applications therapeutiques et vaccinales |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA961349B true ZA961349B (en) | 1996-09-05 |
Family
ID=9476320
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA961349A ZA961349B (en) | 1995-02-20 | 1996-02-20 | Amplifying sequences vectors comprising these sequences and their uses in compositions for the expression of nucleotide sequences in transfected cells therapeutic and vaccine applications |
Country Status (15)
Country | Link |
---|---|
US (2) | US5914395A (xx) |
EP (1) | EP0811071B1 (xx) |
JP (1) | JPH11500905A (xx) |
AT (1) | ATE212060T1 (xx) |
AU (1) | AU710697B2 (xx) |
CA (1) | CA2211435A1 (xx) |
DE (1) | DE69618574T2 (xx) |
DK (1) | DK0811071T3 (xx) |
ES (1) | ES2168459T3 (xx) |
FR (1) | FR2730735B1 (xx) |
IL (1) | IL117194A0 (xx) |
MX (1) | MX9706290A (xx) |
PT (1) | PT811071E (xx) |
WO (1) | WO1996026284A1 (xx) |
ZA (1) | ZA961349B (xx) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2246664A1 (en) * | 1998-10-02 | 2000-04-02 | Universite Paris 7 | Vascular specific regulatory elements contained in the desmin 5' flanking region |
AU2004263274B2 (en) | 2003-07-21 | 2009-11-05 | Transgene S.A. | Novel multifunctional cytokines |
AU2011230619C1 (en) | 2010-03-25 | 2016-06-23 | Oregon Health & Science University | CMV glycoproteins and recombinant vectors |
EP2691530B1 (en) | 2011-06-10 | 2018-03-07 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
EP2568289A3 (en) | 2011-09-12 | 2013-04-03 | International AIDS Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies |
EP2586461A1 (en) | 2011-10-27 | 2013-05-01 | Christopher L. Parks | Viral particles derived from an enveloped virus |
ES2631608T3 (es) | 2012-06-27 | 2017-09-01 | International Aids Vaccine Initiative | Variante de la glicoproteína Env del VIH-1 |
JP6430949B2 (ja) | 2012-10-23 | 2018-11-28 | エモリー ユニバーシティ | Gm−csfとil−4のコンジュゲート、組成物、ならびにそれに関連する方法 |
US20150065381A1 (en) | 2013-09-05 | 2015-03-05 | International Aids Vaccine Initiative | Methods of identifying novel hiv-1 immunogens |
US10058604B2 (en) | 2013-10-07 | 2018-08-28 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
AU2015208247B2 (en) * | 2014-01-21 | 2021-05-27 | Universiteit Gent | Muscle-specific nucleic acid regulatory elements and methods and use thereof |
EP3069730A3 (en) | 2015-03-20 | 2017-03-15 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
US9931394B2 (en) | 2015-03-23 | 2018-04-03 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3723075A1 (de) * | 1987-07-11 | 1989-01-19 | Boehringer Mannheim Gmbh | Eukaryotische expressionsvektoren mit multimeren enhancer-subelementen, verfahren zu ihrer herstellung und verwendung |
US5503980A (en) * | 1992-11-06 | 1996-04-02 | Trustees Of Boston University | Positional sequencing by hybridization |
-
1995
- 1995-02-20 FR FR9501937A patent/FR2730735B1/fr not_active Expired - Fee Related
-
1996
- 1996-02-16 US US08/894,228 patent/US5914395A/en not_active Expired - Fee Related
- 1996-02-16 PT PT96904158T patent/PT811071E/pt unknown
- 1996-02-16 DE DE69618574T patent/DE69618574T2/de not_active Expired - Fee Related
- 1996-02-16 DK DK96904158T patent/DK0811071T3/da active
- 1996-02-16 CA CA002211435A patent/CA2211435A1/fr not_active Abandoned
- 1996-02-16 AT AT96904158T patent/ATE212060T1/de not_active IP Right Cessation
- 1996-02-16 ES ES96904158T patent/ES2168459T3/es not_active Expired - Lifetime
- 1996-02-16 EP EP96904158A patent/EP0811071B1/fr not_active Expired - Lifetime
- 1996-02-16 JP JP8525445A patent/JPH11500905A/ja active Pending
- 1996-02-16 MX MX9706290A patent/MX9706290A/es not_active IP Right Cessation
- 1996-02-16 AU AU48356/96A patent/AU710697B2/en not_active Ceased
- 1996-02-16 WO PCT/FR1996/000261 patent/WO1996026284A1/fr active IP Right Grant
- 1996-02-20 ZA ZA961349A patent/ZA961349B/xx unknown
- 1996-02-20 IL IL11719496A patent/IL117194A0/xx unknown
-
1998
- 1998-11-13 US US09/191,521 patent/US6201115B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69618574T2 (de) | 2002-08-14 |
CA2211435A1 (fr) | 1996-08-29 |
AU4835696A (en) | 1996-09-11 |
US5914395A (en) | 1999-06-22 |
ATE212060T1 (de) | 2002-02-15 |
IL117194A0 (en) | 1996-06-18 |
AU710697B2 (en) | 1999-09-30 |
US6201115B1 (en) | 2001-03-13 |
DE69618574D1 (de) | 2002-02-21 |
JPH11500905A (ja) | 1999-01-26 |
PT811071E (pt) | 2002-07-31 |
EP0811071B1 (fr) | 2002-01-16 |
MX9706290A (es) | 1998-02-28 |
WO1996026284A1 (fr) | 1996-08-29 |
FR2730735A1 (fr) | 1996-08-23 |
DK0811071T3 (da) | 2002-04-29 |
EP0811071A1 (fr) | 1997-12-10 |
ES2168459T3 (es) | 2002-06-16 |
FR2730735B1 (fr) | 1997-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA961349B (en) | Amplifying sequences vectors comprising these sequences and their uses in compositions for the expression of nucleotide sequences in transfected cells therapeutic and vaccine applications | |
EP1209237A3 (en) | Synthetic DNA sequence having enhanced insecticidal activity in maize | |
HUP0204199A2 (hu) | Transzport vektorok | |
AU8067698A (en) | Chimeric vectors comprising a phage packaging site and a portion derived from a genome of a eukaryotic virus | |
DE69429631D1 (en) | Conotoxinpeptide | |
AU6871398A (en) | Method for enhancing expression of a foreign or endogenous gene product in pla nts | |
AU2003264419A1 (en) | Kdr peptides and vaccines containing the same | |
IL133544A0 (en) | Lag-3 splice variants, their preparation and use | |
WO2001036623A3 (en) | Ecdysone-inducible adeno-associated virus expression vectors | |
WO2003093417A3 (en) | Lentiviral vector particles resistant to complement inactivation | |
CA2327266A1 (en) | Pesticidal toxins and nucleotide sequences which encode these toxins | |
AU6724794A (en) | GRB3-3 gene, its variants and their uses | |
WO1999028439A3 (fr) | Erythrovirus et ses applications | |
FR2685004B1 (xx) | ||
AU5776799A (en) | Modified hcv peptide vaccines | |
WO2000012741A3 (fr) | Systeme d'expression inductible | |
ATE327321T1 (de) | Zyklische depsipeptid-synthasen, deren gene und system zur massenproduktion von zyklischen depsipeptiden | |
GB9416536D0 (en) | Orphan receptor | |
AU782261C (en) | Novel glycosyltransferase genes | |
HUP0004857A2 (hu) | T. variabilisból származó D-aminosav oxidáz promótere | |
ES2161130A1 (es) | Dna recombinante derivado del virus de la sharka y vector de expresion de proteinas heterologas basado en dicho dna recombinante. | |
HUP0104598A1 (hu) | Hepatocita-eredetű növekedési faktorból (HGF) és makrofágstimuláló proteinből (MSP) származó rekombináns proteinek | |
CA2419038A1 (en) | Nucleic acid and protein increasing expression levels under salt stress | |
EP1158052A4 (en) | BETA-PRIMEVEROSIDASDE GENE |